Vaccinex Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Net Income	-18.63	-20.25	-19.82	-22.38	-28.85	Upgrade
Depreciation & Amortization	0.09	0.12	0.21	0.17	0.31	Upgrade
Stock-Based Compensation	0.34	0.47	0.55	0.54	0.73	Upgrade
Other Operating Activities	-0.09	-2.04	-	-0.42	0.23	Upgrade
Change in Accounts Receivable	0.12	-0.79	-0.18	0.16	0.74	Upgrade
Change in Accounts Payable	1.91	0.52	0.46	-2.11	0.12	Upgrade
Change in Unearned Revenue	-0.06	0.06	-	-	-	Upgrade
Change in Other Net Operating Assets	0.13	0.52	-0.29	-1.26	-1.93	Upgrade
Operating Cash Flow	-16.19	-21.38	-19.07	-25.3	-28.65	Upgrade
Capital Expenditures	-0.02	-0.07	-0.1	-0.03	-0.29	Upgrade
Investing Cash Flow	-0.02	-0.07	-0.1	-0.03	-0.29	Upgrade
Long-Term Debt Issued	-	-	-	-	9.13	Upgrade
Long-Term Debt Repaid	-0.08	-0.07	-0.08	-8.54	-0.11	Upgrade
Net Debt Issued (Repaid)	-0.08	-0.07	-0.08	-8.54	9.03	Upgrade
Issuance of Common Stock	13.05	12.27	17.05	32.85	28.49	Upgrade
Other Financing Activities	1.11	4.39	-	-0.99	-0.76	Upgrade
Financing Cash Flow	15.78	16.59	16.98	23.32	36.76	Upgrade
Net Cash Flow	-0.43	-4.86	-2.2	-2.01	7.82	Upgrade
Free Cash Flow	-16.21	-21.45	-19.17	-25.33	-28.94	Upgrade
Free Cash Flow Margin	-2696.84%	-3762.46%	-6972.00%	-2814.44%	-4629.92%	Upgrade
Free Cash Flow Per Share	-7.72	-46.25	-94.88	-184.38	-323.46	Upgrade
Levered Free Cash Flow	-11.54	-11.11	-11.8	-17.07	-18.49	Upgrade
Unlevered Free Cash Flow	-11.54	-11.11	-11.8	-16.57	-18.19	Upgrade
Change in Net Working Capital	0.25	-2.67	0.01	3.19	1.23	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.